[1]
|
The Alan Guttmacher Institute (1998) Into a new world —young women’s sexual and reproductive lives: Young women in a changing world. New York, 5-9.
|
[2]
|
Treffers, P.E., Olukoya, A.A., Ferguson, B.J. and Liljestrand, J. (2001) Care for adolescent pregnancy and childbirth. International Journal of Gynecology & Obstetrics, 75, 111-121.
doi:10.1016/S0020-7292(01)00368-X
|
[3]
|
Okonofua, F.E. (2004) Editorial: Breaking the silence on prevention of unsafe abortion in Africa. African Journal of Reproductive Health, 8, 7-8. doi:10.2307/3583174
|
[4]
|
Population Council (2001) Misoprostol: An emerging technology for women’s health, report of a seminar. Shannon, C.S. and Winikoff, B., Eds., New York, 2.
|
[5]
|
Ellertson, C., Elul, B. and Winikoff, B. (1997) Can women use medical abortion without medical supervision? Reproductive health matters, 9, 149-161.
doi:10.1016/S0968-8080(97)90019-7
|
[6]
|
Elul, B. (1998) Medical methods of early abortion in developing countries. Consensus statement, Contraception, 58, 257-259. doi:10.1016/S0010-7824(98)00109-7
|
[7]
|
Winikoff, B., Siviel, Coyaji, K.J., et al. (1997) Safety efficacy and acceptability of medical abortion in China, Cuba and India: A comparative trial of mifepristone—misoprostol versus surgical abortion. American Journal of Obstetrics & Gynecology, 176, 431-437.
doi:10.1016/S0002-9378(97)70511-8
|
[8]
|
Carabonell, J.L., Velazco, A., Varela, L., Tanda, R., Sanchez, C., Barambio, S., Chami, S., Valero, F.-A., Sanchez, S. and Mari, J. (2001) Misoprostol for abortion at 9 weeks - 12 weeks gestation in adolescents. European Journal of Contraception and Reproductive Healthcare, 6, 39-45. doi:10.1080/13625180008500367
|
[9]
|
Carabonell, J.L., Varela, L., Velazco, A., Tanda, R., Barambio, S. and Chami, S. (2000) Vaginal misoprostol 600 microgram for early abortion. European Journal of Contraception and Reproductive Healthcare, 5, 46-51
|
[10]
|
Herabutya, Y., Chanrachakul, B. and Punyavachira, P. (2001) Second trimester pregnancy termination: A comparison of 600 and 800 micrograms of intravaginal misoprostol. Journal of Obstetrics and Gynaecological Research, 27, 125-128.
doi:10.1111/j.1447-0756.2001.tb01235.x
|
[11]
|
Wong, K.S., Ngai, C.S., Yeo, E.L., Tang, L.C. and Ho, P.C. (2000) A comparism of two regimens of intravaginal misoporstol for termination of second trimester pregnancy: A randomized comparative trial. Human Reproduction, 15, 709-712. doi:10.1093/humrep/15.3.709
|
[12]
|
Rabe, T., Basse, H., Thuro, H., Kiesel, L. and Runnebaum, B. (1987) Effect of the PGE1 methyl analog misoprostol on the pregnant uterus in the first trimester. Geburtshilfe Frauenheilkd, 47, 324-331.
doi:10.1055/s-2008-1035830
|
[13]
|
Norman, J.E., Thong, K.J. and Baird, D.T. (1991) Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone. Lancet, 338, 1233-1236.
doi:10.1016/0140-6736(91)92102-8
|
[14]
|
Carabonell, J.L., Varela, L., Velazco, A. and Fernandez, C. (1997) The use of misoprostol for early termination of pregnancy. Contraception, 55, 165-168.
doi:10.1016/S0010-7824(97)00020-6
|
[15]
|
Carabonell, J.L., Varela, L., Velazco, A., Fernandez, C. and Sanchez, C. (1997) The use of misoprostol for abortion at < or = 9 weeks gestation. European Journal of Contraception and Reproductive Healthcare, 2, 181-185.
|
[16]
|
Adjase, E.T. (2004) Misoprostol, an emerging technology for women’s health, report of a seminar. Shannon, C.S. and Winikoff, B., Eds., Population Council, New York, 200, 5-12.
|
[17]
|
World Health Organization (1994) Abortion: A tabulation of available data on the frequency and mortality of unsafe abortion. 2nd Edition, Geneva, Switzerland.
|
[18]
|
Ibrahim, S.A., Iliyasu, Z. and Musa, J. (2006) Maternal mortality in Jos University Teaching Hospital, Nigeria. Trop Journal of Obstetrics and Gynaecology, 23, 152-155.
|